Effect of Albumin Platelet-Rich Fibrin or Leucocyte- Platelet-Rich Fibrin on Immediate Implant
NCT ID: NCT06863051
Last Updated: 2025-08-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
20 participants
INTERVENTIONAL
2025-08-20
2027-02-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
L-PRF vs Connective Tissue With Customized Healing Abutment in Immediate Implant Placement
NCT07102758
Effect of "Autogenous Leukocyte Platelet Rich Fibrin- Tooth Graft" Combination Around Immediately Placed Implants
NCT04795102
Clinical and Radiographic Outcome of Regeneration in Immature Permanent Human Teeth Using a New Scaffold
NCT06812351
Clinical Comparison of Alb-PRF Vs PRF on Postoperative Morbidity Following FGG Harvesting
NCT06567548
Injectable Platelet Rich Fibrin With Collagen Matrix in Treatment of Multiple Gingival Recession.
NCT05389059
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Peri-implant vertical defect depth.
* Crestal bone level.
* Bucco-lingual bone width.
* Keratinized tissue width
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Albumin-PRF group
Immediate Implant Placement in lower molar region, Grafted with Xenograft and Albumin PRF Gel
Immediate Implant Placement and Alb-PRF
Immediate Implant Placement in lower molar region, Grafted with Xenograft and Albumin PRF Gel
L-PRF group
Immediate Implant Placement in lower molar region, Grafted with Xenograft and L-PRF ( L-PRF Block )
Immediate Implant Placement and L-PRF
Immediate Implant Placement in lower molar region, Grafted with Xenograft and L-PRF
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Immediate Implant Placement and Alb-PRF
Immediate Implant Placement in lower molar region, Grafted with Xenograft and Albumin PRF Gel
Immediate Implant Placement and L-PRF
Immediate Implant Placement in lower molar region, Grafted with Xenograft and L-PRF
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient 18-45 years old
* Intact buccal and lingual walls
* Good oral hygiene.
* Prescence of sufficient restorative space.
* Jumping gap more than 2 mm.
Exclusion Criteria
* Acute localized infection (suppuration at the surgical field)
* Patients on chemotherapy or radiotherapy.
* Patients who have systemic disorders (diseases) {diabetes mellitus, autoimmune disease, …etc},
* Pregnant patients.
* Smoking and Alcohols.
* Presence of periapical pathology affecting the neighboring teeth.
18 Years
45 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kafrelsheikh University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mostafa Fayed
Demonstrator of Periodontology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kafrelsheikh University, Faculty of Dentistry
Kafr ash Shaykh, Kafrelsheikh, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KFSIRB200-531
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.